Physician profile
Noah Allen
NPI 1992095038
$7,415.82
in general payments reported to CMS, 2019-2025
37 companies · $2,032 in 2025
The $2,032 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,791 · 2020: $302 · 2021: $453 · 2022: $656 · 2023: $553 · 2024: $629 · 2025: $2,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,116 · Travel and Lodging: $1,099.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,116.08 |
| Travel and Lodging | $1,098.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,897.31 | 2019-2020 | |
| Teleflex LLC | $1,843.27 | 2021-2025 | Urolift, Barrigel |
| Abbvie INC. | $450.88 | 2022-2025 | Botox |
| Astellas Pharma US INC | $391.06 | 2019-2022 | |
| Rochester Medical Corporation | $340.29 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $227.43 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $212.33 | 2023-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Medtronic USA, INC. | $164.09 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $160.03 | 2023-2025 | Gemtesa |
| Boston Scientific Corporation | $139.44 | 2019-2024 | Lithovue |
| Axonics, INC. | $124.94 | 2020-2022 | |
| Janssen Biotech, INC. | $120.17 | 2019-2020 | |
| Antares Pharma, INC. | $118.90 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Endo Pharmaceuticals INC. | $117.83 | 2019-2024 | Xiaflex, Aveed |
| Coloplast Corp | $117.34 | 2019-2023 | Porges Coloplast |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $108.99 | 2019-2025 | Cysto-Nephro Videoscope, Itind System, Olympus |
| Merck Sharp & Dohme LLC | $94.39 | 2020-2023 | Keytruda, Lynparza |
| Urogen Pharma, INC. | $75.94 | 2022-2024 | |
| Procept Biorobotics Corporation | $70.70 | 2019-2024 | Aquabeam System |
| Ferring Pharmaceuticals INC. | $70.66 | 2019-2025 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $65.28 | 2019-2024 | Provenge |
| Amgen INC. | $60.98 | 2019-2023 | Prolia |
| Myriad Genetic Laboratories, INC. | $48.46 | 2022-2023 | Prolaris |
| Progenics Pharmaceuticals, INC. | $47.01 | 2024 | |
| Halozyme INC | $46.58 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.77 | 2019-2025 | |
| Myovant Sciences INC. | $39.83 | 2021-2022 | |
| Pfizer INC. | $37.32 | 2020-2024 | |
| Calyxo, INC. | $34.04 | 2025 | Cvac Aspiration System |
| Urovant Sciences INC | $29.41 | 2022 | |
| Civco Medical Instruments | $23.83 | 2024 | |
| Medtronic, INC. | $23.38 | 2021 | |
| Immunitybio, INC. | $16.07 | 2025 | |
| Photocure INC | $14.53 | 2024 | Cysview |
| Srs Medical Systems, INC. | $14.01 | 2023 | Urocuff |
| Blue Earth Diagnostics | $12.48 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noah Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.